RESUMO
Understanding the mechanism of action of organophosphates (OP)/nerve agents -- irreversible acetylcholinesterase (AChE, EC 3.1.1.7) inhibition at the cholinergic synapses followed by metabolic dysbalance of the organism -- two therapeutic principles for antidotal treatment are derived. The main drugs are anticholinergics that antagonize the effects of accumulated acetylcholine at the cholinergic synapses and cholinesterase reactivators (oximes) reactivating inhibited AChE. Anticonvulsants such as diazepam are also used to treat convulsions. Though there are experimental data on a good therapeutic effects of reactivators, some attempts to underestimate the role of reactivators as effective antidotes against OP poisoning have been made. Some arguments on the necessity of their administration following OP poisoning are discussed. Their distribution patterns and some metabolic and pharmacological effects are described with the aim to resolve the question on their effective use, possible repeated administration in the treatment of OP poisoning, their peripheral and central effects including questions on their penetration through the blood brain barrier as well as a possibility to achieve their effective concentration for AChE reactivation in the brain. Reactivation of cholinesterases in the peripheral and central nervous system is described and it is underlined its importance for the survival or death of the organism poisoned with OP. Metabolization and some other effects of oximes (not connected with AChE reactivation) are discussed (e.g. forming of the phosphonylated oxime, parasympatholytic action, hepatotoxicity, behavioral changes etc.). An universality of oximes able to reactivate AChE inhibited by all OP is questioned and therefore, needs of development of new oximes is underlined.
Assuntos
Antídotos/uso terapêutico , Reativadores da Colinesterase/farmacocinética , Colinesterases/efeitos dos fármacos , Neurotransmissores/farmacocinética , Compostos Organofosforados/farmacocinética , Oximas/farmacocinética , Praguicidas/farmacocinética , Acetilcolina/análise , Antídotos/administração & dosagem , Antídotos/química , Barreira Hematoencefálica/efeitos dos fármacos , Reativadores da Colinesterase/administração & dosagem , Reativadores da Colinesterase/química , Reativadores da Colinesterase/uso terapêutico , Diazepam/uso terapêutico , Humanos , Estrutura Molecular , Neurotransmissores/intoxicação , Intoxicação por Organofosfatos , Oximas/administração & dosagem , Oximas/química , Praguicidas/química , Convulsões/tratamento farmacológicoRESUMO
This article presents the latest study results on lead (Pb2+) neurotoxicity, in order to draw attention of the Polish public to the issue and initiate a nation-wide programme eliminating lead contamination effects, especially in children. We discuss the after-effect of exposure to lead in concentrations lower than presently accepted as 'safe'. The pathway of lead transport to the brain, and the effects of lead accumulation in neurons, oligodendroglia and astroglia, are examined. We also present the impairing influence of lead on the cognitive brain functions and learning abilities as a result of affecting three main neurotransmission systems: dopaminergic, cholinergic and glutaminergic. The present knowledge on the influence of lead on receptors, neutransmitter release and synaptic proteins.
Assuntos
Comportamento Animal/efeitos dos fármacos , Química Encefálica/efeitos dos fármacos , Intoxicação por Chumbo/sangue , Intoxicação por Chumbo/líquido cefalorraquidiano , Chumbo/toxicidade , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Animais , Relação Dose-Resposta a Droga , Exposição Ambiental , Humanos , Chumbo/metabolismo , Intoxicação por Chumbo/fisiopatologia , Intoxicação por Chumbo/prevenção & controle , Intoxicação do Sistema Nervoso por Chumbo na Infância/fisiopatologia , Síndromes Neurotóxicas/fisiopatologia , Neurotransmissores/intoxicação , RatosRESUMO
In Canada in late 1987 there was an outbreak of an acute illness characterized by gastrointestinal symptoms and unusual neurologic abnormalities among persons who had eaten cultivated mussels. Health departments in Canada solicited reports of this newly recognized illness. A case was defined as the occurrence of gastrointestinal symptoms within 24 hours or of neurologic symptoms within 48 hours of the ingestion of mussels. From the more than 250 reports received, 107 patients met the case definition. The most common symptoms were vomiting (in 76 percent of the patients), abdominal cramps (50 percent), diarrhea (42 percent), headache, often described as incapacitating (43 percent), and loss of short-term memory (25 percent). Nineteen patients were hospitalized, of whom 12 required intensive care because of seizures, coma, profuse respiratory secretions, or unstable blood pressure. Male sex and increasing age were associated independently with the risks of hospitalization and memory loss. Three patients died. Mussels associated with this illness were traced to cultivation beds in three river estuaries on the eastern coast of Prince Edward Island. Domoic acid, which can act as an excitatory neurotransmitter, was identified in mussels left uneaten by the patients and in mussels sampled from these estuaries. The source of the domoic acid appears to have been a form of marine vegetation, Nitzschia pungens, also identified in these waters in late 1987. The contaminated mussels from Prince Edward Island were removed from the market, and no new cases have occurred since December 1987. We conclude that the cause of this outbreak of a novel and severe intoxication was the ingestion of mussels contaminated by domoic acid, a potent excitatory neurotransmitter.
Assuntos
Encefalopatias/induzido quimicamente , Surtos de Doenças , Contaminação de Alimentos , Ácido Caínico/análogos & derivados , Toxinas Marinhas/intoxicação , Neurotransmissores/intoxicação , Adulto , Fatores Etários , Idoso , Animais , Bivalves , Canadá , Feminino , Seguimentos , Doenças Transmitidas por Alimentos/etiologia , Gastroenteropatias/etiologia , Humanos , Ácido Caínico/intoxicação , Masculino , Transtornos da Memória/etiologia , Pessoa de Meia-Idade , Ilha do Príncipe Eduardo , Fatores SexuaisRESUMO
In late 1987 there was an outbreak in Canada of gastrointestinal and neurologic symptoms after the consumption of mussels found to be contaminated with domoic acid, which is structurally related to the excitatory neurotransmitter glutamate. We studied the neurologic manifestations in 14 of the more severely affected patients and assessed the neuropathological findings in 4 others who died within four months of ingesting the mussels. In the acute phase of mussel-induced intoxication, the patients had headache, seizures, hemiparesis, ophthalmoplegia, and abnormalities of arousal ranging from agitation to coma. On neuropsychological testing several months later, 12 of the patients had severe anterograde-memory deficits, with relative preservation of other cognitive functions. Eleven patients had clinical and electromyographic evidence of pure motor or sensorimotor neuronopathy or axonopathy. Positron-emission tomography of four patients showed decreased glucose metabolism in the medial temporal lobes. Neuropathological studies in the four patients who died after mussel-induced intoxication demonstrated neuronal necrosis and loss, predominantly in the hippocampus and amygdala, in a pattern similar to that observed experimentally in animals after the administration of kainic acid, which is also structurally similar to glutamate and domoic acid. We conclude that intoxication with domoic acid causes a novel and distinct clinicopathologic syndrome characterized initially by widespread neurologic dysfunction and then by chronic residual memory deficits and motor neuronopathy or axonopathy.
Assuntos
Contaminação de Alimentos , Ácido Caínico/análogos & derivados , Toxinas Marinhas/intoxicação , Neurotransmissores/intoxicação , Animais , Bivalves , Encéfalo/metabolismo , Surtos de Doenças , Eletromiografia , Glucose/metabolismo , Humanos , Ácido Caínico/intoxicação , Transtornos da Memória/induzido quimicamente , Neurônios Motores , Mioclonia/induzido quimicamente , Necrose , Doenças do Sistema Nervoso/induzido quimicamente , Doenças Neuromusculares/induzido quimicamente , Ilha do Príncipe Eduardo , Convulsões/induzido quimicamente , Lobo Temporal/metabolismo , Tomografia Computadorizada de EmissãoRESUMO
Gamma-hydroxybutyrate (GHB), a compound found in the mammalian brain, meets many criteria of a neurotransmitter. Experimentally, GHB has been used as a model for petit mal epilepsy; clinically it has been used as a general anaesthetic, to treat certain sleep disorders and alcoholism. Lately GHB has been abused for its euphoric, sedative and anabolic effects. Coma and seizures following abuse of GHB have been reported, but dependency has received little attention. Adverse effects of GHB include seizure activity and a withdrawal syndrome characterised by insomnia, anxiety and tremor. The present paper reviews the neuropharmacology, potential therapeutic uses and acute adverse effects of GHB, together with a presentation of three cases.